Insider · CIK 0001639637
Karen L. Smith
Files at SGMOQ (SANGAMO THERAPEUTICS, INC), SKYE (Skye Bioscience, Inc.), AUPH (Aurinia Pharmaceuticals Inc.), CNTX (Context Therapeutics Inc.). First filing Nov 12, 2024, latest Nov 12, 2024.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AUPH: Aurinia Pharmaceuticals Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 24Weak | Aurinia Pharmaceuticals Inc. | $44k 5,241 shares | -29% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 102,100 | Jun 16, 2025 |
| Jun 12, 2025 | SGMOQ SANGAMO THERAPEUTICS, INC | AGrant or award Stock Option (Right to Buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Jun 16, 2025 |
| Jun 12, 2025 | CNTX Context Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +123,500 | $0.00 | $0 | 123,500 | Jun 12, 2025 |
| Nov 21, 2024 | AUPH Aurinia Pharmaceuticals Inc. | AGrant or award Common Shares | +12,135 | $0.00 | $0 | 24,807 | Nov 25, 2024 |
| Nov 21, 2024 | AUPH Aurinia Pharmaceuticals Inc. | AGrant or award Director Stock Option (right to buy)derivative | +18,641 | $0.00 | $0 | 18,641 | Nov 25, 2024 |
| Nov 8, 2024 | AUPH Aurinia Pharmaceuticals Inc. | MOption exercise Common Stock | +17,913 | - | - | 17,913 | Nov 12, 2024 |
| Nov 11, 2024 | AUPH Aurinia Pharmaceuticals Inc. | SOpen-market sale Common Stock | -5,241 | $8.43 | $44k | 12,672 | Nov 12, 2024 |
| Nov 8, 2024 | AUPH Aurinia Pharmaceuticals Inc. | MOption exercise Restricted Stock Unitsderivative | -17,913 | $0.00 | $0 | 0 | Nov 12, 2024 |
| Oct 28, 2024 | SKYE Skye Bioscience, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +70,000 | $0.00 | $0 | 70,000 | Oct 30, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.